Pharma Journalist -

Vertex Pharmaceuticals Incorporated announced that eligible cystic fibrosis patients living in Scotland will now have access to ORKAMBI (lumacaftor/ivacaftor) and SYMKEVI…
Read More...

GlaxoSmithKline announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for use in children as young as six years old who are living with severe…
Read More...

Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Investigational Medicinal Product (IMP) and Wholesale Distribution…
Read More...

Aytu BioScience, a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs and Innovus Pharmaceuticals, a specialty…
Read More...

SMi Reports: London awarded top spot for Trip Advisor Travellers’ Choice Awards 2019 where SMi’s Inaugural Pharmaceutical Manufacturing & Cleanroom Technology conference will take…
Read More...

Dance Biopharm Holdings, Inc., a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, announced it has formed a strategic alliance with…
Read More...

Hansoh Pharmaceutical Group Company Limited and Atomwise have announced a collaboration to design and discover potential drug candidates for up to eleven undisclosed target proteins in…
Read More...

Avalon Ventures announced that it entered into a definitive agreement with GlaxoSmithKline (GSK) for the acquisition of Sitari Pharmaceuticals by GSK. Sitari has been developing a novel…
Read More...

Mallinckrodt plc, a global biopharmaceutical company, today announced it has entered into a definitive agreement to sell its wholly owned subsidiary BioVectra Inc. to an affiliate of…
Read More...

Q BioMed, Inc. and Chemveda Life Sciences are very pleased to announce that after the recent successful chemical synthesis of a unique natural compound that has shown remarkable…
Read More...